What you want to know:

– Qure.ai, a world innovator in AI for medical imaging, as we speak introduced crucial 510(okay) FDA clearance for its AI-powered chest CT scanning resolution – qCT LN Quant.

– The brand new AI resolution is now obtainable to assist radiologists and pulmonologists in analyzing lung nodules on non-contrast chest CT scans and in monitoring volumetric development as a part of development monitoring.

Qure.ai Improves Lung Most cancers Care with AI-Powered qCT LN Quant

Qure.ai has built-in qCT LN Quant into its AI-powered lung most cancers care continuum within the US, providing complete options to establish, measure, handle, and monitor lung well being. These instruments assist clinicians throughout healthcare settings, drive early detection, and enhance affected person outcomes.

Key parts of Qure.ai's lung well being options embody:

– qXR LN: Facilitates early detection and localization of lung nodules on chest X-ray, extending lung most cancers detection capabilities past conventional CT-based screening strategies.

– qTrack: a multimodal lung nodule administration platform that seamlessly integrates with digital medical data (EMRs), enabling clinicians to effectively discover, report, collaborate, and prioritize lung most cancers sufferers.

qCT LN Quant gives superior quantitative characterization of strong lung nodules, with options together with:

– Measurement choices:

– Evaluation of imply, short-axis, long-axis and efficient diameters of pulmonary nodules.

– Analysis of morphological information from a number of thoracic examinations.

– Estimation of quantity doubling time and monitoring of nodules over a number of time factors.

– Superior imaging and resolution assist:

– Era of detailed 2D and 3D reconstructions.

– Calculation of Brock threat scores for malignancy.

– Offering administration recommendations primarily based on Fleischner Society tips to make sure constant and dependable medical resolution making.

– Reimbursement circumstances:

– Attainable eligibility beneath two CPT codes, together with tissue quantification CPT 0722T for CT and 3D reconstruction code.

Qure.ai’s options are trusted globally, with real-world AI deployments in over 3,000 places throughout 90+ international locations. The corporate has established partnerships, business deployments, and ongoing analysis research with main establishments together with AstraZeneca, the UK’s Nationwide Well being Service (NHS) hospitals, and main teleradiology corporations within the UK and US. Qure.ai is headquartered in Mumbai, with regional workplaces in New York and London.